Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00037648
Status:
COMPLETED
Last Update Posted:
2009-11-26
First Post:
2002-05-17
Brief Title:
Juvenile Rheumatoid Arthritis
Sponsor:
Amgen
Organization:
Swedish Orphan Biovitrum
Study Overview
Official Title:
A Randomized Multi-center Blinded Placebo-controlled Study With an Open-label Run-in Period to Evaluate the Efficacy Safety and Pharmacokinetics of Daily Single Subcutaneous Injections of r-metHuIL-1ra Anakinra in Polyarticular-Course Juvenile Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety of anakinra in patients with Polyarticular-Course Juvenile Rheumatoid Arthritis a form of rheumatoid arthritis affecting children
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None